microRNA-34a is tumor suppressive in brain tumors and glioma stem cells
暂无分享,去创建一个
Yunqing Li | Ying Zhang | Benjamin Purow | David Schiff | D. Schiff | Yunqing Li | R. Abounader | B. Purow | Alessia Catania | Ying Zhang | Roger Abounader | Fadila Guessous | Alex Kofman | Alessia Catania | F. Guessous | A. Kofman | A. Catania
[1] D. Schiff,et al. Interactions between PTEN and the c-Met pathway in glioblastoma and implications for therapy , 2009, Molecular Cancer Therapeutics.
[2] Marc Ladanyi,et al. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[3] Naoto Tsuchiya,et al. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells , 2007, Proceedings of the National Academy of Sciences.
[4] D. Schiff,et al. Functional and molecular interactions between the HGF/c-Met pathway and c-Myc in large-cell medulloblastoma , 2008, Laboratory Investigation.
[5] L. Lim,et al. A microRNA component of the p53 tumour suppressor network , 2007, Nature.
[6] C. Eberhart,et al. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy. , 2005, Cancer research.
[7] Yi Tie,et al. Downregulation of CCND1 and CDK6 by miR‐34a induces cell cycle arrest , 2008, FEBS letters.
[8] J Khan,et al. The MYCN oncogene is a direct target of miR-34a , 2008, Oncogene.
[9] Yunqing Li,et al. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. , 2008, Cancer research.
[10] Yuri Kotliarov,et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.
[11] Carlos Caldas,et al. Sizing up miRNAs as cancer genes , 2005, Nature Medicine.
[12] V. Tarasov,et al. Differential Regulation of microRNAs by p53 Revealed by Massively Parallel Sequencing: miR-34a is a p53 Target That Induces Apoptosis and G1-arrest , 2007, Cell cycle.
[13] Yi Tie,et al. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. , 2009, Cancer letters.
[14] C. Croce,et al. MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.
[15] Carola Berking,et al. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer , 2008, Cell cycle.
[16] Yunqing Li,et al. Signaling pathways in medulloblastoma , 2008, Journal of cellular physiology.
[17] C. Croce,et al. MicroRNAs in Cancer. , 2009, Annual review of medicine.
[18] W. Filipowicz,et al. Repression of protein synthesis by miRNAs: how many mechanisms? , 2007, Trends in cell biology.
[19] H. Dietz,et al. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression. , 1999, Journal of the National Cancer Institute.
[20] Michael A. Beer,et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. , 2007, Molecular cell.
[21] Yunqing Li,et al. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. , 2009, Cancer research.
[22] V. Ambros,et al. Identification of microRNAs and other tiny noncoding RNAs by cDNA cloning. , 2004, Methods in molecular biology.
[23] Q. Su,et al. Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. , 2005, Cancer research.
[24] R. Stallings,et al. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells , 2007, Oncogene.
[25] Bernat Gel,et al. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. , 2009, Carcinogenesis.
[26] Moshe Oren,et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. , 2007, Molecular cell.
[27] S. Nakano,et al. Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans. , 1998, Cancer letters.
[28] D. Schiff,et al. PTEN has tumor-promoting properties in the setting of gain-of-function p53 mutations. , 2008, Cancer research.
[29] J. Laterra,et al. Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis. , 2005, Neuro-oncology.
[30] A W Langerak,et al. 17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation , 2009, Leukemia.
[31] M. Yamakuchi,et al. miR-34a repression of SIRT1 regulates apoptosis , 2008, Proceedings of the National Academy of Sciences.
[32] Q. Su,et al. Notch-1 regulates transcription of the epidermal growth factor receptor through p53. , 2008, Carcinogenesis.